MedTrace Logo

Asparagus Capsule Consumption and Blood Sugar and Lipids and Oxidative Stress

NCT06195813 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2024-01-12

No results posted yet for this study

Summary

Participants were 44 overweight and obese persons, male and female, age 18-59 years. Participants were divided into 2 groups consisting of 23 asparagus capsules and 21 placebo capsules groups. They received health screenings including history taking, mental health questionnaire, and vital signs, height and body weight, body composition, fat distribution measurements and oral glucose tolerance test. Then, a venipuncture was conducted to determine blood glucose, insulin, lipids malondialdehyde and protein carbonyl levels.

Conditions

  • Asparagus Capsule Consumption

Interventions

DIETARY_SUPPLEMENT

Asparagus capsule

Asparagus capsule is categorized as dietary supplement.

OTHER

Placebo capsule

Placebo capsule is categorized as other.

Sponsors & Collaborators

  • Burapha University

    lead OTHER

Principal Investigators

  • Piyapong Prasertsri, Ph.D. · Burapha University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-20
Primary Completion
2023-09-14
Completion
2023-09-14

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06195813 on ClinicalTrials.gov